Enzymatic fluorometric assay for cAMP and adenylate cyclase
AssigneeFuso Pharmaceutical Industries, Ltd.
InventorAtsushi Sugiyama
Life of this patent
Estimating the term…
Loading patent…
AssigneeFuso Pharmaceutical Industries, Ltd.
InventorAtsushi Sugiyama
Estimating the term…
The present invention relates to a method for quickly determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides without the use of radioactive agents. Particularly, the present invention provides a method of determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides selected from the group consisting of cAMP produced by endogenous adenylate cyclase, and AMP, ATP, ADP and a mixture thereof, which comprises (1) combining a biological sample with effective amounts of apyrase, adenosine deaminase and alkaline phosphatase to enzymatically remove non-cyclic adenine nucleotides other than cAMP, and glucose-6-phosphate in the sample; (2) enzymatically converting cAMP into AMP; (3) determining an amount of AMP without the use of radioactive agents, and a kit to carry out the method.
A method of determining cAMP content or an adenylate cyclase activity in a biological sample comprising the following steps:
Dependencies are inferred from the claim text.